Hasil Filter

11778

Total database: 17430
Struktur (SMILES)
8554 (72.6%)
Target
6383 (54.2%)
Genomik
96 (0.8%)
Referensi
11778 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (11778)

Halaman 43 / 236
Amrubicin DB06263
small molecule | CAS: 110267-81-7

Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on P…

Kategori:
Anthracyclines and Related SubstancesAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +4
Target Protein:
DNA topoisomerase 2-alphaDNA
Waktu Paruh20-30 h [A32143] …
Vol. DistribusiModerate volume of …
KlirensThe plasma pharmaco…
Genetik -
Amsacrine Approved DB00276
small molecule | CAS: 51264-14-3

Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other …

Kategori:
AcridinesAminoacridinesAntineoplastic Agents +11
Target Protein:
DNADNA topoisomerase 2-betaDNA topoisomerase 2-alpha +3
Waktu Paruh8-9 hours
Vol. Distribusi-
Klirens-
Genetik -
AMT-080 DB17846
biotech

AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AMT-130 DB16975
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AMT-162 DB17922
biotech

AMT-162 is an adeno-associated virus serotype rh10 encoding artificial anti-SOD1 miRNA.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 87344-05-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amubarvimab DB16493
biotech | CAS: 2509447-07-6

Amubarvimab (BRII-196) was under investigation in clinical trials (NCT04691180 and NCT04787211) to treat COVID-19, focusing on its safety, tolerability, and efficacy.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amuvatinib DB12742
small molecule | CAS: 850879-09-3

Amuvatinib has been used in trials studying the treatment of Solid Tumors and Small Cell Lung Carcinoma. Amuvatinib is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuv…

Kategori:
AmidesSulfur Compounds
Target Protein:
Platelet-derived growth factor receptor alphaMast/stem cell growth factor receptor KitHepatocyte growth factor receptor +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AMY-101 DB14803
small molecule | CAS: 1427001-89-5

AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).

Kategori:
Amino Acids, Peptides, and ProteinsPeptides
Target Protein:
Complement C3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amyl acetate DB15927
small molecule | CAS: 628-63-7

Deskripsi belum tersedia.

Kategori:
AlcoholsFatty AlcoholsLipids
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amyl Nitrite Approved DB01612
small molecule | CAS: 8017-89-8

Amyl Nitrite is an antihypertensive medicine. Amyl nitrite is employed medically to treat heart diseases such as angina and to treat cyanide poisoning. Its use as a prescription medicine comes from its ability to lower blood pressure. As an inhalant, it also …

Kategori:
Antianginal AgentsAntidotesCardiovascular Agents +5
Target Protein:
Atrial natriuretic peptide receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amylamine DB02045
small molecule | CAS: 110-58-7

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amylmetacresol Approved DB13908
small molecule | CAS: 1300-94-3

Amylmetacresol is an antiseptic available in Canada over-the-counter in a number of lozenges for the treatment of sore throat and minor mouth infections [L2570], [L2571]. Amylmetacresol is often combined with dichlorobenzyl alcohol and menthol in the commonl…

Kategori:
Anti-Infective Agents, LocalBenzene DerivativesMiscellaneous Anti-infectives +1
Target Protein:
Sodium channel protein type 2 subunit alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amylopectin DB14927
small molecule | CAS: 9037-22-3

Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors).

Kategori:
CarbohydratesDietary CarbohydratesGlucans +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Amylose DB15216
small molecule | CAS: 9005-82-7

Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).

Kategori:
CarbohydratesDietary CarbohydratesGlucans +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AMZ002 DB17017
biotech

AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AN-2718 DB12810
small molecule | CAS: 174672-06-1

An2718 has been used in trials studying Tinea Pedis.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
AN2898 DB16039
small molecule | CAS: 906673-33-4

AN2898 is under investigation in clinical trial NCT01301508 (Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-moderate Atopic Dermatitis).

Target Protein:
3',5'-cyclic-AMP phosphodiesterase 4D3',5'-cyclic-AMP phosphodiesterase 4B3',5'-cyclic-AMP phosphodiesterase 4A
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ANA971 DB05127
small molecule

ANA971, an orally administered prodrug of isatoribine. Isatoribine is a nucleoside analog in development for the treatment of chronic hepatitis C virus (HCV) infection. ANA971 is a prodrug designed to improve the oral bioavailability of isatoribine. ANA971 re…

Target Protein:
Toll-like receptor 7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ANA975 DB06490
small molecule | CAS: 847453-47-8

ANA975 is a toll-like receptor 7 agonist that is developed for the treatment of hepatitis C.

Target Protein:
Toll-like receptor 7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anacaulase Approved DB17449
biotech

Anacaulase (anacaulase-bcdb) is a mixture of proteolytic enzymes extracted from the stems of pineapple plants (_Ananas comosus_ [L.] Merr.). It is mostly composed (80-95% w/w) of proteins such as stem bromelain, ananain, jacalin-like lectin, bromelain inhibit…

Kategori:
Administration, TopicalCysteine EndopeptidasesCytochrome P-450 CYP2C8 Inhibitors +9
Target Protein:
Alpha-1-antichymotrypsinAlpha-2-macroglobulin
Waktu ParuhThe mean eliminatio…
Vol. Distribusi-
Klirens-
Genetik -
Anacetrapib DB06630
small molecule | CAS: 875446-37-0

Deskripsi belum tersedia.

Kategori:
Anticholesteremic AgentsCholesterol Ester Transfer Proteins, antagonists & inhibitorsHypolipidemic Agents +2
Target Protein:
Cholesteryl ester transfer protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anagliptin DB12417
small molecule | CAS: 739366-20-2

Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.

Kategori:
Agents causing angioedemaBlood Glucose Lowering AgentsDPP-IV Inhibitors +2
Target Protein:
Dipeptidyl peptidase 4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anagrelide Approved DB00261
small molecule | CAS: 68475-42-3

Anagrelide is a platelet-reducing agent used to lower dangerously elevated platelet levels (i.e. to treat thrombocythemia) in patients with myeloproliferative neoplasms.[L14153] It is an oral imidazoquinazoline that was first approved for use in the US in 199…

Kategori:
Agents producing tachycardiaAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +18
Target Protein:
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Waktu ParuhThe t<sub>1/2</sub>…
Vol. Distribusi-
Klirens-
Genetik -
Anakinra Approved DB00026
biotech | CAS: 143090-92-0

Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist (IL-1Ra) composed of 153 amino acid residues. Unlike native human IL-1Ra, anakinra has an additional methionine residue at the amino terminus. This drug binds to the IL-1 receptor, compe…

Kategori:
Agents reducing cytokine levelsAmino Acids, Peptides, and ProteinsAntineoplastic and Immunomodulating Agents +12
Target Protein:
Interleukin-1 receptor type 1
Waktu ParuhIn patients with rh…
Vol. DistribusiIn adult subjects w…
KlirensIn patients with rh…
Genetik -
Ananain DB18353
biotech | CAS: 119129-70-3

Deskripsi belum tersedia.

Kategori:
Cysteine ProteasesEndopeptidasesEnzymes +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anaritide DB17613
biotech | CAS: 95896-08-5

Deskripsi belum tersedia.

Kategori:
Amino Acids, Peptides, and ProteinsDiureticsHormones +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anastrozole Approved DB01217
small molecule | CAS: 120511-73-1

Anastrozole is a non-steroidal aromatase inhibitor (AI), similar to [letrozole], used to decrease circulating estrogen levels in the treatment of postmenopausal women with estrogen-responsive breast cancer.[L8863] Anastrozole is also related to [exemestane], …

Kategori:
Antineoplastic AgentsAntineoplastic Agents, HormonalAntineoplastic and Immunomodulating Agents +30
Target Protein:
Aromatase
Waktu ParuhThe elimination hal…
Vol. DistribusiThe volume of distr…
KlirensAnastrozole's clear…
Genetik -
Anatibant DB05038
small molecule | CAS: 209733-45-9

Anatibant is a selective, very potent, small-molecule Bradykinin B2 receptor antagonist. It is developed for the for the treatment of traumatic brain injury (TBI).

Kategori:
Bradykinin Receptor AntagonistsHeterocyclic Compounds, Fused-Ring
Target Protein:
B2 bradykinin receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anbenitamab DB18411
biotech | CAS: 2367012-88-0

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ANC-501 DB18907
small molecule | CAS: 1370444-22-6

ANC-501 is under investigation in clinical trial NCT05439603 (ANC-501 in the Treatment of Adults With Major Depressive Disorder).

Kategori:
AcetatesAcids, AcyclicAmides +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ancestim Approved DB09103
biotech | CAS: 163545-26-4

Ancestim is a non-glycosylated recombinant methionyl human stem cell factor. It is a 166 amino acid protein produced by E. coli with an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the ad…

Kategori:
Adjuvants, ImmunologicAmino Acids, Peptides, and ProteinsAntineoplastic and Immunomodulating Agents +8
Target Protein:
Mast/stem cell growth factor receptor Kit
Waktu ParuhIn clinical trials,…
Vol. DistribusiPreclinical reports…
KlirensThe apparent cleara…
Genetik -
Andarine DB07423
small molecule | CAS: 401900-40-1

Andarine is a non-steroidal selective androgen receptor modulator.

Kategori:
AcetatesAcids, AcyclicAmides +4
Target Protein:
Androgen receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Andecaliximab DB17564
biotech | CAS: 1518996-49-0

Andecaliximab is a monoclonal antibody directed against matrix metallopeptidase 9 (MMP9). Andecaliximab is under investigation in clinical trial NCT03631836 (Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, i…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Andexanet alfa Approved DB14562
biotech | CAS: 1262449-58-0

Andexanet alfa is a recombinant human coagulation Factor Xa that promotes blood coagulation. It was developed by Portola Pharmaceuticals and was approved in in May 2018. It is marketed as Andexxa for intravenous injection or infusion and is indicated for the …

Kategori:
Amino Acids, Peptides, and ProteinsAntidotesBiological Factors +12
Target Protein:
Tissue factor pathway inhibitor
Waktu ParuhThe elimination hal…
Vol. DistribusiThe volume of distr…
KlirensClearance for andex…
Genetik -
Andrographolide DB05767
small molecule | CAS: 5508-58-7

Andrographolide (HMPL-004) is a botanical product extracted from a herb that occurs naturally in China. The herb has an extensive history of use in TCM for the treatment of upper respiratory tract infections and other inflammatory and infectious diseases.

Kategori:
AcanthaceaeAnalgesicsAnalgesics, Non-Narcotic +25
Target Protein:
Tumor necrosis factorInterleukin-1 betaInterleukin-6 +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Androstanedione DB01561
small molecule | CAS: 846-46-8

Deskripsi belum tersedia.

Target Protein:
17-beta-hydroxysteroid dehydrogenase type 1Steroid Delta-isomerase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Androstenediol DB01524
small molecule | CAS: 521-17-5

Androstenediol is an intermediate in [testosterone] biosynthesis, found in the testis or the adrenal glands. Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testoste…

Kategori:
Anabolic AgentsAndrostanesAndrostenediols +9
Target Protein:
Estrogen receptorEstrogen receptor beta
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Androstenedione DB01536
small molecule | CAS: 63-05-8

A delta-4 C19 steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol.

Kategori:
17-KetosteroidsAdrenal Cortex HormonesAndrostanes +12
Target Protein:
Aromatase17-beta-hydroxysteroid dehydrogenase type 13 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Andusomeran Approved DB18227
biotech | CAS: 2918977-08-7

Andusomeran is a COVID-19 mRNA vaccine developed for use during the 2023-2024 season.[L40074,L48832,L48837] It is similar to previous mRNA vaccines developed by Moderna (e.g. [elasomeran], [imelasomeran]), but is designed to be effective against the Omicron X…

Kategori:
COVID-19 VaccinesmRNA VaccinesVaccines +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ANEB-001 DB18908
small molecule | CAS: 791848-71-0

ANEB-001 is under investigation in clinical trial NCT05282797 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anecortave DB12081
small molecule | CAS: 10184-70-0

Anecortave is under investigation in clinical trial NCT00691717 (Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension).

Kategori:
11-Hydroxycorticosteroids17-HydroxycorticosteroidsAdrenal Cortex Hormones +17
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 7753-60-8

Anecortave acetate (Retaane) is an analog of cortisol acetate; among the modifications to the steroid are the removal of the 11ß hydroxyl OH group and an addition of a 21-acetate group. As a result of these modifications, anecortave acetate lacks the typical …

Kategori:
11-Hydroxycorticosteroids17-HydroxycorticosteroidsAngiogenesis Inhibitors +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anethole trithione Approved DB13853
small molecule | CAS: 532-11-6

Anethole trithione (ATT) appears to have a broad range of unique functions, from increasing salivary secretion to help treat xerostomia [A27165, A32618, A32620, A32621], to demonstrating an ability to inhibit carcinogenesis by increasing the activity of elect…

Kategori:
Alimentary Tract and MetabolismAnisolesBenzene Derivatives +10
Target Protein:
Protein-glutamine gamma-glutamyltransferase 2
Waktu ParuhDespite the medicat…
Vol. DistribusiDespite the medicat…
KlirensDespite the medicat…
Genetik -
biotech | CAS: 1375258-01-7

Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibody-drug Conjugates +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Anfibatide DB15094
biotech | CAS: 1622134-89-7

Anfibatide is under investigation in clinical trial NCT01585259 (Anfibatide Phase Ib-IIa Clinical Trial).

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsComplex Mixtures +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
ANG1005 DB18167
biotech

Deskripsi belum tersedia.

Kategori:
Amino Acids, Peptides, and ProteinsCyclodecanesCycloparaffins +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Angiotensin 1-7 DB11720
small molecule | CAS: 51833-78-4

TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.

Kategori:
Amino Acids, Peptides, and ProteinsAngiotensinsAntihypertensive Agents +13
Target Protein:
Proto-oncogene Mas
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Angiotensin II Approved DB11842
biotech | CAS: 4474-91-3

Angiotensin II is under investigation for the treatment of Sepsis, Septic Shock, Diabetes Mellitus, and Acute Renal Failure. Angiotensin II has been investigated for the treatment, basic science, and diagnostic of Hypertension, Renin Angiotensin System, and I…

Kategori:
Amino Acids, Peptides, and ProteinsAngiotensin II, antagonists & inhibitorsAngiotensins +16
Target Protein:
Type-2 angiotensin II receptorType-1 angiotensin II receptor
Waktu ParuhThe plasma half-lif…
Vol. DistribusiThe official prescr…
KlirensThe official prescr…
Genetik -
biotech | CAS: 53-73-6

Deskripsi belum tersedia.

Kategori:
Amino Acids, Peptides, and ProteinsAngiotensinsAutacoids +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 2101–2150 dari 11778
Sebelumnya Halaman 43 / 236 Berikutnya